← Back to Clinical Trials
Recruiting NCT06866535

NCT06866535 VIP - Vascular Infection Project

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06866535
Status Recruiting
Phase
Sponsor University Hospital, Bordeaux
Condition Aortitis
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2022-05-10
Primary Completion 2032-05-10

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2022-05-10 with a primary completion date of 2032-05-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Constitution of a prospective multicentric observational database to study vascular infections, both native, especially aortitis, and vascular graft and endograft infections. Clinical and paraclinical data on medical, surgical, anesthetic and intensive care management will be collected in order to better characterize these infections

Eligibility Criteria

Inclusion Criteria: * ≥ 18 years-old; * all patients with a vascular infection, either native (aortitis, arteritis) or prosthetic (vascular graft, endograft and/or stent), * oral consent Exclusion Criteria: * patient under legal protection

Contact & Investigator

Central Contact

Mathilde Puges, MD

✉ mathilde.puges@chu-bordeaux.fr

📞 +335 56 79 55 36

Frequently Asked Questions

Who can join the NCT06866535 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Aortitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06866535 currently recruiting?

Yes, NCT06866535 is actively recruiting participants. Contact the research team at mathilde.puges@chu-bordeaux.fr for enrollment information.

Where is the NCT06866535 trial being conducted?

This trial is being conducted at Bordeaux, France.

Who is sponsoring the NCT06866535 clinical trial?

NCT06866535 is sponsored by University Hospital, Bordeaux. The trial plans to enroll 1,000 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology